Champions Oncology, Inc. (CSBR)
4.94
+0.06
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
5.17
+0.23
(+4.66%)
After-Hours: 20:00
Champions Oncology Profit Margin (Quarterly) : -2.80% for July 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -2.80% |
| April 30, 2026 | -4.82% |
| January 31, 2026 | -1.68% |
| October 31, 2025 | 1.58% |
| July 31, 2025 | -3.33% |
| April 30, 2025 | -14.85% |
| January 31, 2025 | 26.38% |
| October 31, 2024 | 5.40% |
| July 31, 2024 | 9.34% |
| April 30, 2024 | -0.78% |
| January 31, 2024 | -21.05% |
| October 31, 2023 | -17.90% |
| July 31, 2023 | -20.43% |
| April 30, 2023 | -19.59% |
| January 31, 2023 | -19.10% |
| October 31, 2022 | -0.11% |
| July 31, 2022 | -2.32% |
| April 30, 2022 | -2.67% |
| January 31, 2022 | 5.97% |
| October 31, 2021 | 2.35% |
| July 31, 2021 | -1.53% |
| April 30, 2021 | -4.55% |
| January 31, 2021 | 8.87% |
| October 31, 2020 | 0.01% |
| July 31, 2020 | 0.79% |
| Date | Value |
|---|---|
| April 30, 2020 | -24.18% |
| January 31, 2020 | 4.52% |
| October 31, 2019 | 4.03% |
| July 31, 2019 | -9.51% |
| April 30, 2019 | -3.27% |
| January 31, 2019 | -5.74% |
| October 31, 2018 | 3.99% |
| July 31, 2018 | 7.74% |
| April 30, 2018 | -13.45% |
| January 31, 2018 | -1.50% |
| October 31, 2017 | -1.81% |
| July 31, 2017 | -13.39% |
| April 30, 2017 | -65.16% |
| January 31, 2017 | -39.52% |
| October 31, 2016 | -11.31% |
| July 31, 2016 | -69.37% |
| April 30, 2016 | -90.73% |
| January 31, 2016 | -94.51% |
| October 31, 2015 | -85.76% |
| July 31, 2015 | -103.2% |
| April 30, 2015 | -113.5% |
| January 31, 2015 | -154.0% |
| October 31, 2014 | -163.5% |
| July 31, 2014 | -185.6% |
| April 30, 2014 | -92.43% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 17.16% |
| Avantor, Inc. | 2.25% |
| Personalis, Inc. | -141.7% |
| Adaptive Biotechnologies Corp. | -55.82% |
| 10X Genomics, Inc. | -11.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.45% |
| Return on Assets | -3.80% |
| Return on Invested Capital | -10.79% |
| Gross Profit Margin (Quarterly) | 48.48% |
| Operating Margin (Quarterly) | -2.69% |
| Return on Net Operating Assets | -5.05% |